Building trust: How life sciences organizations can manage risk and drive transformation

Webcast overview

In today’s interconnected world, life sciences organizations are faced with many internal and external pressures. These disruptions offer a unique opportunity for their risk and compliance functions to transform their business processes and earn stakeholder trust.

Join KPMG for a panel discussion on the different disruptions affecting the life sciences sector. Professionals from our Technology Risk Management, Internal Audit, and Quality and Regulatory service networks will discuss potential risks, areas to focus on, what regulators are looking for, and the steps organizations can take to navigate these risks and turn them into opportunities.

Specifically, we will discuss:

  • Preliminary insights from the 2022 KPMG Healthcare and Life Sciences Technology Risk Survey
  • Automating and digitizing quality processes
  • Driving efficiencies in computer systems validation
  • Latest trends for the Internal Audit function to consider
  • Effectively working across the three lines of defense

Who should attend this webcast: Professionals in the life sciences sector, specifically those in the following business functions: Internal Audit, Quality and Regulatory, Information Technology and Security, and Risk and Compliance.

Continuing professional education

You may qualify for approximately one continuing professional education (CPE) credit when you attend this program. State boards of accountancy have final authority on the acceptance of individual course credits. No advance preparation or prerequisite is required for this program. This event is brought to you with our compliments.

Additional information

For more information, please contact KPMG at KPMG Events & Meetings

We hope you can join us.

While you’re here: Participate in our Healthcare and Life Sciences Technology Risk Survey

Take our brief survey to help your organization: identify key technologies that healthcare and life sciences organizations are implementing, compare how you are working across the lines of defense against how your peers are, and identify how regulatory compliance objectives are being addressed. Results will be compiled into an anonymous report where you can benchmark your results against your industry peers.

Click here to participate.


Jennifer Shimek

Jennifer Shimek

Principal, Advisory, KPMG US

Featured Speakers

Jason Glantz

Jason Glantz

Managing Director, Technology Risk Management, KPMG US

Timothy Johnson

Timothy Johnson

Managing Director, Life Sciences Advisory, KPMG US

Maria Arosteguy

Maria Arosteguy

Principal, KPMG LLP